In terms of clinical significance, T. gondii infection can progress from the latent phase to the active phase through a decrease in CD8+ and CD4+ cells, which may lead to dangerous complications in COVID-19 patients [15, 22]. The gene discussed is CD4; the disease is COVID-19.